Cargando…
Treating Patients with Aripiprazol: A Safe Gamble?
INTRODUCTION: Aripiprazole (ARI) is an atypical antipsychotic drug with D2 partial agonist properties, usually prescribed to treat mood disorders (major depression or bipolar disorder) and schizophrenic disorder (schizophrenia or schizoaffective disorder). Dopamine receptor agonists, as is ARI, have...
Autores principales: | Leal, B., Vila-Chã, D., Garcia, S., Pinto, I., Mateiro, R., Avelino, M., Martins, M., Salgado, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9567850/ http://dx.doi.org/10.1192/j.eurpsy.2022.1838 |
Ejemplares similares
-
Nitrous Oxide in Treatment Resistant Major Depression: Should We Laugh About It?
por: Leal, B., et al.
Publicado: (2022) -
The impact of SARS-CoV-2 pandemic on suicidal ideation admissions: a single adolescent and young adult psychiatry center experience
por: Vila-Chã, D., et al.
Publicado: (2022) -
Mental Health Refugees - Difficulties from the country of origin to the receiving country – A review
por: Vila-Chã, D., et al.
Publicado: (2022) -
Aripiprazol and Hypersexuality: when partial is to much
por: Espada-Santos, P., et al.
Publicado: (2022) -
PS154. Aripiprazole may be effective for treating apathy after cerebral infarction
por: Mukai, Keiichiro, et al.
Publicado: (2016)